Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 97,551 | 61,122 | 26,904 | 197,673 | 85,777 |
| Depreciation Amortization | 6,463 | 4,306 | 2,123 | 8,853 | 6,726 |
| Income taxes - deferred | 9,848 | 5,045 | 3,425 | -84,280 | N/A |
| Accounts receivable | -87,674 | -59,726 | -49,413 | -22,578 | -22,719 |
| Accounts payable and accrued liabilities | 4,533 | 9,409 | 142 | 4,150 | 208 |
| Other Working Capital | -117,075 | -79,755 | -56,751 | -18,539 | -32,262 |
| Other Operating Activity | 101,111 | 61,063 | 53,895 | 33,393 | 30,726 |
| Operating Cash Flow | $14,757 | $1,464 | $-19,675 | $118,672 | $68,456 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21,491 | -7,123 | -4,701 | -8,226 | -5,469 |
| Purchase Sale Intangibles | -124 | -124 | -19 | -349 | -356 |
| Other Investing Activity | -124 | -124 | -19 | -349 | -356 |
| Investing Cash Flow | $-21,615 | $-7,247 | $-4,720 | $-8,575 | $-5,825 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 72,500 | 30,000 | N/A | N/A | -30,000 |
| Debt Repayment | -74,282 | -30,375 | N/A | -60,825 | N/A |
| Common Stock Issued | 2,554 | 2,165 | 101 | 7,494 | 7,051 |
| Common Stock Repurchased | -23,038 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -12,638 | -8,869 | -7,228 | -4,971 | -4,327 |
| Financing Cash Flow | $-34,904 | $-7,079 | $-7,127 | $-58,302 | $-27,276 |
| Beginning Cash Position | 103,147 | 103,147 | 103,147 | 51,352 | 51,352 |
| End Cash Position | 61,385 | 90,285 | 71,625 | 103,147 | 86,707 |
| Net Cash Flow | $-41,762 | $-12,862 | $-31,522 | $51,795 | $35,355 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,757 | 1,464 | -19,675 | 118,672 | 68,456 |
| Capital Expenditure | -21,491 | -7,123 | -4,701 | -8,226 | -5,469 |
| Free Cash Flow | -6,734 | -5,659 | -24,376 | 110,446 | 62,987 |